Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 4 boards, counting each seat separately. Longest: Axogen Inc., 3 years.
Axogen Inc.
Director
Bioventus Inc.
Director
Elutia Inc.
Director
TELA Bio Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 9, 2026 | TELA Bio Inc. | Grant or award | +11,925 | — | — |
| Jun 9, 2026 | TELA Bio Inc. | Grant or award | +11,675 | — | — |
| Jun 2, 2026 | Bioventus Inc. | Option exercise | +32,282 | — | — |
| Jan 30, 2026 | Elutia Inc. | Open-market purchase | +20,000 | $1.04 | $20,800 |
| Jan 29, 2026 | Elutia Inc. | Open-market purchase | +15,000 | $1.06 | $15,900 |
| Jan 28, 2026 | Elutia Inc. | Open-market purchase | +15,000 | $1.06 | $15,900 |
| Dec 10, 2025 | Elutia Inc. | Option exercise | +6,250 | — | — |
| Dec 1, 2025 | Elutia Inc. | Option exercise | +6,250 | — | — |
| Jun 9, 2025 | Axogen Inc. | Open-market sale | −4,073 | $10.61 | $43,215 |
| Jun 2, 2025 | Bioventus Inc. | Option exercise | +26,493 | — | — |
| Sep 1, 2024 | Axogen Inc. | Option exercise | +11,904 | — | — |
| Jun 7, 2024 | Bioventus Inc. | Option exercise | +30,400 | — | — |
| Jun 6, 2024 | Axogen Inc. | Grant or award | +10,653 | — | — |
| Aug 16, 2023 | Axogen Inc. | Open-market purchase | +10,000 | $6.11 | $61,100 |
| Jun 6, 2023 | Bioventus Inc. | Option exercise | +16,648 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.